Fundz

Spectral AI

Dallas, Texas, United States · Artificial Intelligence, Biotechnology, Health Care

Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView® System. DeepView® is a predictive diagnostic device

Key facts

Headquarters
Dallas, Texas, United States
Employees
79
Industries
Artificial Intelligence, Biotechnology, Health Care
Status
Public (MDAI)
Website
www.spectral-ai.com
LinkedIn
Company page

Recent activity at Spectral AI

  • : Spectral AI Appoints Darcy Bajko as Chief Commercial Officer
  • : SPECTRAL AI Secures $31.7 Million Funding from BARDA
  • : SEC 8-K (7.01): On September 14, 2026, Spectral AI, Inc. posted an investor presentation on its website. This presentation is intended for use in communications with investors and analysts, providing insights into the company's operations and strategic direction. The document is categorized as a Regulation FD Disclosure, highlighting its significance for market participants. The inclusion of this presentation in the filing suggests the company's proactive approach to keeping investors informed about its initiatives and policies.
  • : SEC 8-K (7.01): On August 11, 2026, Spectral AI, Inc. issued a press release disclosing its financial results for the quarter ended June 30, 2026. This release provides key insights into the company's financial performance and is deemed important for its security holders. The information included in the press release is not considered 'filed' under the Securities Exchange Act or the Securities Act, which highlights its informational nature rather than a formal report. The release aims to provide transparency regarding the company's financial standing and must be diligently monitored by investors for potential impacts on stock valuation.
  • : SEC 8-K (5.02): Spectral AI, Inc. has appointed Darcy Bajko as the Chief Commercial Officer, effective July 31, 2026. Mrs. Bajko previously held leadership roles at MediView XR where she was instrumental in commercializing augmented reality technologies, generating over $2.2 million in revenue. In her new role, she will receive an annual base salary of $315,000 and will be eligible for performance-based bonuses. Additionally, she will receive stock options to acquire 150,000 shares under the Company’s Long Term Incentive Plan, with provisions for full vesting upon a change of control. The filing and accompanying press release were issued on July 8, 2026, which highlights the Company's strategic move to enhance their leadership team.
  • : SEC 8-K (7.01): On June 1, 2026, Spectral AI, Inc. issued a press release announcing the results of its Annual Meeting. This disclosure includes important information pertaining to corporate governance and shareholder engagement. The filed press release serves to inform stakeholders about the outcomes and decisions made during the meeting, although specific details regarding the nature of the outcomes were not included in the filing. This communication is significant for shareholders and may impact perceptions of the company's direction and leadership. The filing ensures compliance with Regulation FD by disseminating this material information to the public.
  • : SEC 8-K (7.01): On May 26, 2026, Spectral AI, Inc. announced via press release that the U.S. Food and Drug Administration granted De Novo Classification for its DeepView® System, allowing the company to begin commercial distribution in the United States. This significant regulatory approval marks a key milestone for the company, potentially enhancing its market position in the healthcare sector. The announcement is detailed in a press release attached as Exhibit 99.1 to the Form 8-K.
  • : SEC 8-K (5.02):
  • : SEC 8-K (5.02): Spectral AI, Inc. announced the appointment of David McGuire as Chief Financial Officer, effective May 4, 2026. McGuire, who has over 20 years of experience in finance and accounting, previously served as Chief Accounting Officer at Solo Brands, Inc. He will receive an annual base salary of $330,000 and is eligible for a target bonus of up to 30%. Additionally, he will be granted stock options to acquire 150,000 shares of common stock, with vesting conditions that include full vesting upon a change of control of the Company. This appointment is part of the Company’s strategy to bolster its financial leadership and enhance its financial planning and reporting capabilities.
  • : SEC 8-K (7.01): On March 24, 2026, Spectral AI, Inc. issued a press release detailing its financial results for the quarter and year ended December 31, 2025. This disclosure is part of the Company's ongoing communication strategy under Regulation FD, aimed at providing financial transparency to its investors. The press release is included as Exhibit 99.1 in the Form 8-K filing. The timing of this announcement is critical as it informs shareholders and potential investors about the Company's financial performance and operational status, impacting future investment decisions.

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Spectral AI funding history

DateRoundAmount
Mar 2026Funding Round$31.7M
Oct 2025Funding Round$7.6M
Mar 2024Seed$1.0M

Leadership

  • Fred Zuber, Director of Manufacturing Operations
  • Darcy Bajko, Chief Commercial Officer
  • Stan Micek, Chief Operating Officer
  • Vincent S. Capone, Chief Executive Officer
  • Stanley Micek, Chief Operating Officer
  • Jeremiah A. Sparks, Chief Commercial Officer
  • Wensheng Fan, Chief Innovation Strategist

Verified email and direct lines for Spectral AI’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Spectral AI in the news

Companies similar to Spectral AI

  • EchoIQ Limited · Artificial Intelligence, Biotechnology, Health Care, Image Recognition, Information Technology, Machine Learning
  • Intelligent Ultrasound Group PLC · Artificial Intelligence, Biotechnology, Health Care, Image Recognition, Information Technology, Machine Learning
  • Hoppr · Artificial Intelligence, Biotechnology, Health Care, Image Recognition, Machine Learning
  • Odysight.ai · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Machine Learning
  • Blackford Analysis · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Machine Learning

About Spectral AI: questions and answers

What does Spectral AI do?

Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView® System. DeepView® is a predictive diagnostic device

Where is Spectral AI headquartered?

Spectral AI is headquartered in Dallas, Texas, United States.

How many employees does Spectral AI have?

Spectral AI has about 79 employees.

Has Spectral AI raised funding?

Yes. Fundz has recorded 3 funding events for Spectral AI. The most recent, Funding Round of $31.7M, was in Mar 2026.

Who leads Spectral AI?

Vincent S. Capone is a Chief Executive Officer at Spectral AI.

What is the latest news on Spectral AI?

On Aug 11, 2026, Spectral AI Appoints Darcy Bajko as Chief Commercial Officer

Is Spectral AI a public company?

Yes. Spectral AI is publicly traded under the ticker MDAI.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Spectral AI across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.